&nbsp;

May 2022

Drug

daSATinib

Other Name(s): Sprycel®

Quick Link(s):

Feb 2025

Drug

degarelix

Other Name(s): Firmagon®

Quick Link(s):

Feb 2025

Drug

dacarbazine

Quick Link(s):

Jun 2025

Drug

thioguanine

Other Name(s): Lanvis®

Quick Link(s):

Jun 2019

Drug

topotecan

Other Name(s): Hycamtin®

Quick Link(s):

Apr 2023

Drug

temsirolimus

Other Name(s): Torisel ®

Quick Link(s):

Jun 2024

Drug

daBRAFenib

Other Name(s): Tafinlar®

Quick Link(s):

Jun 2025

Drug

trametinib

Other Name(s): Mekinist®

Quick Link(s):

Jun 2025

Regimen

TEMS

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

New Drug Funding Program

Temsirolimus - Metastatic Renal Cell Carcinoma

, Collapse Show fewer tags

Drugs Used:

temsirolimus

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

DASA

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

daSAtinib - Ph+ CML in the chronic phase, with specific criteria

Exceptional Access Program

daSAtinib - Accelerated phase or blast phase Ph+ CML with documented resistance or intolerance to imatinib, with specific criteria

, Collapse Show fewer tags

Drugs Used:

daSATinib

... Show more tags

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

DCRB

Cancer Type:

Sarcoma,

Soft Tissue,

Skin,

Melanoma